Cancer Research SABCS  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 40, 998-1001, April 1, 1980]
© 1980 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ingraham, H. A.
Right arrow Articles by Goulian, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ingraham, H. A.
Right arrow Articles by Goulian, M.

Mechanism for Exclusion of 5-Fluorouracil from DNA1

Holly A. Ingraham2, Ben Y. Tseng and Mehran Goulian3

Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, California 92093

5-Fluorodeoxyuridine 5'-triphosphate is hydrolyzed by the enzyme deoxyuridine triphosphate diphosphohydrolase (EC 3.6.1.23). Uracil-DNA glycosylase removes 5-fluorouracil (FUra) from FUra-containing DNA similar to its removal of uracil from uracil-containing DNA. The absence of FUra in DNA following exposure of cells to FUra can be explained by the activities of these two enzymes.

1 This research was supported by USPHS Research Grant NIH-CA-11705.

2 Recipient of USPHS Institutional Award HL-07107.

3 To whom requests for reprints should be addressed, at Department of Medicine, M-913, University of California, San Diego, La Jolla, Calif. 92093.

Received 8/14/79. Accepted 12/27/79.




This article has been cited by other articles:


Home page
Therapeutic Advances in GastroenterologyHome page
J. M. Carethers
Review: Systemic treatment of advanced colorectal cancer: Tailoring therapy to the tumor
Therapeutic Advances in Gastroenterology, July 1, 2008; 1(1): 33 - 42.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
M. Meyers, M. W. Wagner, A. Mazurek, C. Schmutte, R. Fishel, and D. A. Boothman
DNA Mismatch Repair-dependent Response to Fluoropyrimidine-generated Damage
J. Biol. Chem., February 18, 2005; 280(7): 5516 - 5526.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S.-B. Lin, P. O. P. Ts'o, S.-K. Sun, K.-B. Choo, F.-Y. Yang, Y.-P. Lim, H.-L. Tsai, and L.-C. Au
Inhibition of Thymidylate Synthase Activity by Antisense Oligodeoxynucleotide and Possible Role in Thymineless Treatment
Mol. Pharmacol., September 1, 2001; 60(3): 474 - 479.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Meyers, M. W. Wagner, H.-S. Hwang, T. J. Kinsella, and D. A. Boothman
Role of the hMLH1 DNA Mismatch Repair Protein in Fluoropyrimidine-mediated Cell Death and Cell Cycle Responses
Cancer Res., July 1, 2001; 61(13): 5193 - 5201.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1980 by the American Association for Cancer Research.